Successful medical treatment with octreotide for chyloperitoneum following paraaortic lymphadenectomy in the treatment of gynecologic malignancies: a report of 2 cases.
Chyloperitoneum is a rare and challenging complication following systematic pelvic and retroperitoneal lymphadenectomy in the management of gynecologic malignancies. Despite its infrequent occurrence, postoperative chyloperitoneum is associated with significant morbidity. Two patients developed chyloperitoneum following paraaortic lymphadenectomy for ovarian carcinoma and endometrial carcinoma, respectively. In both cases early infusion of octreotide, a somatostatin analogue, resulted in rapid resolution of chyloperitoneum. There was no evidence of ascites at 6 and 10 months' follow-up, respectively. It is suggested that the early administration of octreotide in the course of chyloperitoneum following paraaortic lymphadenectomy in the treatment of gynecologic malignancies is highly effective and should be initiated early in the course of treatment before any invasive options are considered.